Three-Year Glycemic Trajectories in Subgroups With Type 1 Diabetes at Risk for Suboptimal Glycemic Control: A Multicenter Continuous Glucose Monitoring Study
Diabetes Care · 01.11.2026 · 49 (11) · 2013-2021
DOI: 10.2337/dc26-1039 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetes Care, online erschienen am 16.09.2026. Verfasst von Jee Hee Yoo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of…. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes Mellitus, Type 1, Glycemic Control. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Patient-Centered Clinical Research Coordinating Center (PACEN) funded by the Ministry of Health and Welfare.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE To examine 3-year longitudinal trajectories of continuous glucose monitoring (CGM) metrics across subgroups at risk for suboptimal glycemic control among adults with type 1 diabetes. RESEARCH DESIGN AND METHODS In this multicenter study, 1,028 individuals contributed 3,441 longitudinal CGM profiles. Participants were stratified on the basis of age, chronic kidney disease (CKD), β-cell function, BMI, and triglyceride-glucose (TyG) tertile. Linear mixed-effects models were used to estimate subgroup differences in longitudinal changes. RESULTS At baseline, there was more time spent with glucose above target range (>180 mg/dL), for the subgroups of older age, CKD, severe β-cell failure, higher BMI, and highest TyG tertile (all P < 0.05), while severe β-cell failure was additionally associated with more time spent with glucose below target range (time below range [TBR]) (<70 mg/dL), along with greater glycemic variability (all P < 0.001). In relation to younger individuals, for older adults, improvement in time spent with glucose in target range (time in range [TIR]) (70–180 mg/dL) was comparable (β = 0.110; P = 0.102) and lower TBR was maintained (3.5% vs. 1.7%, respectively; P < 0.001). Among the CKD group, significant improvement in TIR was seen (β = 0.228; P = 0.002) without exacerbation of hypoglycemia. Severe β-cell failure attenuated TIR improvement (β = −0.119; P = 0.025) and TBR reduction (β = 0.046; P < 0.001). Lower absolute TIR was seen for those with higher BMI and those in the highest TyG tertile. Greater TIR improvement was observed for those in the highest TyG tertile (β = 0.083; P = 0.001). CGM metrics varied widely within these subgroups. CONCLUSIONS Older age and CKD were associated with longitudinal glycemic improvement without worsening of hypoglycemia, whereas severe β-cell failure limited glycemic gains; substantial within-group heterogeneity supports individualized glycemic targets informed by CGM trajectories in type 1 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Republic of Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
ORCID-Profile: Jee Hee Yoo, Yeonsoo Park, Jae Hyeon Kim, Soo Heon Kwak, Gyuri Kim
Förderung
- Patient-Centered Clinical Research Coordinating Center (PACEN) funded by the Ministry of Health and Welfare
Zitieren
APA
Yoo, J. H., Kim, S., Park, Y., Park, S., Chung, C. H., Kim, J. H., Kwak, S. H., & Kim, G. (2026). Three-Year Glycemic Trajectories in Subgroups With Type 1 Diabetes at Risk for Suboptimal Glycemic Control: A Multicenter Continuous Glucose Monitoring Study. Diabetes Care, 49(11), 2013-2021. https://doi.org/10.2337/dc26-1039
Vancouver
Yoo JH, Kim S, Park Y, Park S, Chung CH, Kim JH, et al. Three-Year Glycemic Trajectories in Subgroups With Type 1 Diabetes at Risk for Suboptimal Glycemic Control: A Multicenter Continuous Glucose Monitoring Study. Diabetes Care. 2026;49(11):2013-2021. doi:10.2337/dc26-1039
BibTeX
@article{Yoo2026,
author = {Yoo, Jee Hee and Kim, Seohyun and Park, Yeonsoo and Park, Soojin and Chung, Choon Hee and Kim, Jae Hyeon and Kwak, Soo Heon and Kim, Gyuri},
title = {Three-Year Glycemic Trajectories in Subgroups With Type 1 Diabetes at Risk for Suboptimal Glycemic Control: A Multicenter Continuous Glucose Monitoring Study},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {11},
pages = {2013--2021},
doi = {10.2337/dc26-1039}
}
EUVIMED